Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. The Oncologic Drugs ...

Our oceans are changing rapidly, with climate-driven shifts in circulation and nutrient cycles reshaping marine ecosystems in profound ways. One of the most visible and disruptive outcomes is the ...

Oil prices dipped on their first trading day of 2026 after registering their biggest annual loss since 2020 as investors weighed oversupply concerns against geopolitical risks, including the war in ...

Marianne Bonner, CPCU, ARM, covers business insurance topics for Investopedia, building on 30 years of experience working in the insurance industry. She has written extensively for The Risk Report, ...

The Marine Corps' combat fitness test (CFT), taken every six months, is intended to keep Marines ready for the physical rigors of contemporary combat operations. Individual readiness will be measured ...

Jake Paul has revealed his ambition to derail Anthony Joshua's anticipated clash with Tyson Fury scheduled for next year. Fans were shocked last week when Ring Magazine announced that Joshua and Fury ...

Valve Software, creator of Steam, remains privately held, unlikely to IPO soon. Alternative investment options include shares in other public gaming firms like EA or Take-Two. Interested in gaming ...